Literature DB >> 15751565

Treatment of deep vein thrombosis: what factors determine appropriate treatment?

James D Douketis1.   

Abstract

OBJECTIVE: To identify patients with deep vein thrombosis (DVT) for whom in-hospital treatment should be considered. QUALITY OF EVIDENCE: The literature was searched for studies on outpatient treatment of DVT. Seventeen studies were assessed: seven were randomized controlled trials (level I evidence), and 10 were non-randomized trials (level II evidence). MAIN MESSAGE: Four criteria can be used to identify patients with DVT for whom outpatient treatment might not be appropriate: presence of massive DVT, presence of symptomatic pulmonary embolism, high risk of bleeding with anticoagulant therapy, and presence of comorbid conditions or other factors that warrant in-hospital care.
CONCLUSION: Four criteria can be used to identify patients with DVT for whom in-hospital treatment should be considered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15751565      PMCID: PMC1472974     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  35 in total

Review 1.  Antithrombotic therapy for venous thromboembolic disease.

Authors:  T M Hyers; G Agnelli; R D Hull; T A Morris; M Samama; V Tapson; J G Weg
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  Eligibility for home treatment of deep vein thrombosis: prospective study.

Authors:  T Schwarz; B Schmidt; U Höhlein; J Beyer; H E Schröder; S M Schellong
Journal:  BMJ       Date:  2001-05-19

Review 3.  Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.

Authors:  J Hirsh; T E Warkentin; S G Shaughnessy; S S Anand; J L Halperin; R Raschke; C Granger; E M Ohman; J E Dalen
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

4.  Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy.

Authors:  J D Douketis; G A Foster; M A Crowther; M H Prins; J S Ginsberg
Journal:  Arch Intern Med       Date:  2000 Dec 11-25

5.  Outpatient treatment of deep venous thrombosis in diverse inner-city patients.

Authors:  A S Dunn; C Schechter; A Gotlin; D Vomvolakis; E Jacobs; H S Sacks; B Coller
Journal:  Am J Med       Date:  2001-04-15       Impact factor: 4.965

6.  Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?

Authors:  J D Douketis; M A Crowther; G A Foster; J S Ginsberg
Journal:  Am J Med       Date:  2001-05       Impact factor: 4.965

7.  Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology.

Authors:  Albert W Tsai; Mary Cushman; Wayne D Rosamond; Susan R Heckbert; Joseph F Polak; Aaron R Folsom
Journal:  Arch Intern Med       Date:  2002-05-27

8.  Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.

Authors:  G Merli; T E Spiro; C G Olsson; U Abildgaard; B L Davidson; A Eldor; D Elias; A Grigg; D Musset; G M Rodgers; A A Trowbridge; R D Yusen; K Zawilska
Journal:  Ann Intern Med       Date:  2001-02-06       Impact factor: 25.391

9.  Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial.

Authors:  Michael J Kovacs; Marc Rodger; David R Anderson; Beverly Morrow; Gertrude Kells; Judy Kovacs; Eleanor Boyle; Philip S Wells
Journal:  Ann Intern Med       Date:  2003-05-06       Impact factor: 25.391

10.  Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

Authors:  Alexander G G Turpie; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen
Journal:  Arch Intern Med       Date:  2002-09-09
View more
  6 in total

1.  Nontreatment of deep vein thrombosis.

Authors:  Shirley Katz; Susan Rapoport-Glack
Journal:  Can Fam Physician       Date:  2005-05       Impact factor: 3.275

2.  Ambulation after deep vein thrombosis: a systematic review.

Authors:  Cathy M Anderson; Tom J Overend; Julie Godwin; Christina Sealy; Aisha Sunderji
Journal:  Physiother Can       Date:  2009-07-16       Impact factor: 1.037

Review 3.  Management of venous thromboembolism: an update.

Authors:  Siavash Piran; Sam Schulman
Journal:  Thromb J       Date:  2016-10-04

4.  A case of monoclonal gammopathy of undetermined significance and minimal change disease complicated by bilateral pulmonary emboli.

Authors:  Thanuja Neerukonda; Alexandra Witt; Arsen Tan; Bilal Farooqi; Yasna Chaudhary; Christina Kovacs; Luis Silva
Journal:  SAGE Open Med Case Rep       Date:  2022-08-12

5.  American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.

Authors:  Thomas L Ortel; Ignacio Neumann; Walter Ageno; Rebecca Beyth; Nathan P Clark; Adam Cuker; Barbara A Hutten; Michael R Jaff; Veena Manja; Sam Schulman; Caitlin Thurston; Suresh Vedantham; Peter Verhamme; Daniel M Witt; Ivan D Florez; Ariel Izcovich; Robby Nieuwlaat; Stephanie Ross; Holger J Schünemann; Wojtek Wiercioch; Yuan Zhang; Yuqing Zhang
Journal:  Blood Adv       Date:  2020-10-13

Review 6.  Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine Physicians.

Authors:  W Frank Peacock; Zubaid Rafique; Adam J Singer
Journal:  Emerg Med Int       Date:  2016-05-16       Impact factor: 1.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.